Avadel Pharmaceuticals (AVDL) Revenue (2016 - 2020)
Historic Revenue for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to $10.1 million.
- Avadel Pharmaceuticals' Revenue fell 4251.45% to $10.1 million in Q2 2020 from the same period last year, while for Mar 2021 it was $10.1 million, marking a year-over-year decrease of 8165.97%. This contributed to the annual value of -$10.8 million for FY2024, which is N/A changed from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Revenue of $10.1 million as of Q2 2020, which was down 4251.45% from $12.2 million recorded in Q1 2020.
- In the past 5 years, Avadel Pharmaceuticals' Revenue ranged from a high of $52.5 million in Q1 2017 and a low of $10.1 million during Q2 2020
- Moreover, its 5-year median value for Revenue was $30.7 million (2016), whereas its average is $28.3 million.
- In the last 5 years, Avadel Pharmaceuticals' Revenue surged by 1800800.0% in 2016 and then crashed by 5062.93% in 2019.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Revenue stood at $43.1 million in 2016, then decreased by 19.34% to $34.8 million in 2017, then crashed by 39.8% to $20.9 million in 2018, then plummeted by 47.44% to $11.0 million in 2019, then dropped by 8.22% to $10.1 million in 2020.
- Its Revenue was $10.1 million in Q2 2020, compared to $12.2 million in Q1 2020 and $11.0 million in Q4 2019.